Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
26.63
-0.82 (-2.99%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Tango Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 56.99 | 62.38 | 42.07 | 36.53 | 24.86 | 37.04 | |
Revenue Growth (YoY) | 97.27% | 48.29% | 15.17% | 46.93% | -32.89% | 383.83% |
Gross Profit | 56.99 | 62.38 | 42.07 | 36.53 | 24.86 | 37.04 |
Selling, General & Admin | 45.26 | 41.51 | 43.75 | 35.5 | 30.03 | 17.6 |
Research & Development | 129.26 | 132.17 | 143.92 | 115.2 | 105.91 | 77.64 |
Total Operating Expenses | 174.52 | 173.67 | 187.66 | 150.7 | 135.93 | 95.23 |
Operating Income | -117.53 | -111.29 | -145.6 | -114.17 | -111.07 | -58.19 |
Interest Income | 6.19 | 5.63 | 7.89 | 6.62 | 1.46 | 0.5 |
Other Non-Operating Income (Expense) | 4.07 | 4.07 | 7.61 | 5.94 | 1.49 | -0.25 |
Total Non-Operating Income (Expense) | 10.27 | 9.7 | 15.5 | 12.56 | 2.95 | 0.25 |
Pretax Income | -107.26 | -101.59 | -130.09 | -101.61 | -108.12 | -57.94 |
Provision for Income Taxes | 0.03 | -0 | -0.21 | -0.13 | -0.05 | -0.29 |
Net Income | -107.29 | -101.59 | -129.89 | -101.48 | -108.07 | -57.65 |
Net Income to Common | -107.23 | -101.59 | -130.3 | -101.74 | -108.18 | -58.24 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 124 | 116 | 109 | 95 | 88 | 62 |
Shares Outstanding (Diluted) | 126 | 116 | 109 | 95 | 88 | 62 |
Shares Change (YoY) | 18.65% | 6.35% | 15.50% | 7.69% | 41.40% | 94.50% |
EPS (Basic) | -0.82 | -0.87 | -1.19 | -1.08 | -1.23 | -0.94 |
EPS (Diluted) | -0.83 | -0.87 | -1.19 | -1.08 | -1.23 | -0.94 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -142.54 | -139.93 | -132.26 | -119.51 | -116.77 | -61.36 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -1.13 | -1.20 | -1.21 | -1.26 | -1.33 | -0.99 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Operating Margin | -206.22% | -178.39% | -346.09% | -312.57% | -446.79% | -157.09% |
Profit Margin | -188.25% | -162.84% | -308.75% | -277.81% | -434.71% | -155.64% |
FCF Margin | -250.11% | -224.31% | -314.38% | -327.18% | -469.72% | -165.66% |
EBITDA | -115.41 | -109.01 | -143.1 | -111.76 | -109.46 | -57.29 |
EBITDA Margin | -202.50% | -174.74% | -340.15% | -305.96% | -440.32% | -154.67% |
EBIT | -117.53 | -111.29 | -145.6 | -114.17 | -111.07 | -58.19 |
EBIT Margin | -206.22% | -178.39% | -346.09% | -312.57% | -446.79% | -157.09% |
Effective Tax Rate | -0.03% | 0.00% | 0.16% | 0.13% | 0.05% | 0.50% |